Title: Strategic Considerations for Communication and Management of Scientific Uncertainties Due to AI.
Language: Korean.
Abstract: I discuss how AI could affect the communication and management of epistemic contingencies (e.g., inductive risk) that occur during scientific inquiry. To be specific, I discuss the potential epistemic and ethical impacts of AI via historical-philosophical analysis of the argument from inductive risk. I also introduce academic resources for engaging with meta-philosophical challenges posed by the emergence of AI-based technologies.
URL: https://sciphihan.de/.
Title: Evidential Pluralism in Pharmaceutical Regulation.
Language: English.
Abstract: I provide an overview of an emerging area of specialization referred to as “philosophy of pharmaceutical regulation.” As an intersection of disciplines including but not limited to philosophy of science, social epistemology, and political philosophy, philosophy of pharmaceutical regulation addresses various issues concerning the regulatory approval of pharmaceutical products. My overall aim is to highlight research opportunities in light of the problem of evidential pluralism in medicine, i.e., determining whether medical decision-making should be based on diverse types of evidence.
Through a critical literature review, I present three findings. First, philosophy of pharmaceutical regulation has attained distinction via critical engagement with epistemologies of medicine which fail to adequately consider social factors affecting pharmaceutical research. Second, the problem of evidential pluralism motivates deliberations on how regulatory approval processes should be designed in response to how industry interests could adversely affect regulatory decisions. Finally, the problem of evidential pluralism motivates meta-methodological discussions on the role of case studies in substantiating epistemological positions.